Synopsys (SNPS) EBIAT (2009 - 2026)

Synopsys has reported EBIAT for 18 years, with the latest figure at $64.7 million in Q1 2026.

• For the quarter ending Q1 2026, EBIAT fell 78.24% year-over-year to $64.7 million; the trailing twelve-month figure through Jan 2026 stood at $1.1 billion (down 15.92% YoY), and the FY2025 full-year result was $1.3 billion, down 7.52% from the prior year.
• EBIAT for Q1 2026 stood at $64.7 million, down from $445.8 million in the prior quarter.
• The five-year high for EBIAT was $445.8 million in Q4 2025, with the low at $64.7 million in Q1 2026.
• Historically, EBIAT has averaged $297.6 million across 5 years, with a median of $299.1 million in 2024.
• Annual changes were most pronounced in 2023 — EBIAT soared 125.17% — and 2026, when it plunged 78.24%.
• Synopsys' EBIAT stood at $157.7 million in 2022, then soared by 125.17% to $355.1 million in 2023, then decreased by 15.09% to $301.5 million in 2024, then jumped by 47.86% to $445.8 million in 2025, then sank by 85.48% to $64.7 million in 2026.
• The last three EBIAT figures came in at $64.7 million (Q1 2026), $445.8 million (Q4 2025), and $242.3 million (Q3 2025), per Business Quant data.